Skip Navigation
AHRQ--Agency for Healthcare Research and Quality: Advancing Excellence in Health Care
Back to Issue Cover

EHC Program Spotlight: University of Connecticut–Hartford Hospital Evidence-based Practice Center

University of Connecticut EmblemThe University of Connecticut (UCONN) and Hartford Hospital (HH) were jointly selected as an Evidence-based Practice Center (EPC) by the Agency for Healthcare Research and Quality (AHRQ) in July 2007. The UCONN-HH EPC is part of the Health Outcomes Policy and Economics (HOPE) Collaborative Exit Disclaimer, a multifaceted group interested in evidence-based medicine, health economics, and health care policy at the University of Connecticut School of Pharmacy and the Hartford Hospital.

EPCs are top-ranking institutions where research reviews are conducted on behalf of the Effective Health Care (EHC) Program. These centers review existing scientific research about important health care topics to help patients, physicians, and policymakers make better decisions about tests, treatments, or therapies. EPCs produce comparative effectiveness reviews or effectiveness reviews on medications, devices, and other health care services.

C. Michael White, Pharm.D., FCP, FCCP, Professor of Pharmacy Practice at the University of Connecticut School of Pharmacy, is the Director of the UCONN-HH EPC. He is a fellow of both the American College of Clinical Pharmacologists and the American College of Clinical Pharmacists. Working with Dr. White are Co-Director Craig I. Coleman, Pharm.D., Associate Director and Medical Chief Jeffrey Kluge, M.D., FACC, and Project Manager Diana Sobered, Pharm.D. Dr. White's group received the Drug Therapy Research Award, an annual award for the best research publications by a pharmacist, from the American Society for Health System Pharmacists in 2000, 2002, 2004–2006, and 2008.

In October of 2009, the UCONN-HH EPC published a systematic review entitled "Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease" for the EHC Program. Members of the UCONN-HH EPC were also involved in writing a chapter entitled Using Existing Systematic Reviews To Replace De Novo Processes in Comparative Effectiveness Reviews, which was published in the EHC Program’s Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Ongoing and future research projects will continue to utilize the UCONN-HH EPC’s expertise in pharmacology and cardiac therapies.